Neuroblastoma is among the most common and deadly cancers of childhood. While some improvement has been made in the treatment of high-risk neuroblastoma through the escalation of toxic high-dose chemotherapy and immunotherapy, the overall prognosis for these patients is still poor. Alternative approaches using targeted therapy are critically needed.
Ellie was a sweet and sassy little girl who brought joy to everyone around her. Shortly after Ellie turned 2 years old, she was diagnosed with a rare leukemia called JMML. Sadly, Ellie passed away, but never lost her smile throughout her fight.
